Related Experiment Videos
Primary hyperoxaluria type 2
1St Peter's Hospital, London, UK.
Summary
Primary hyperoxaluria type 2 (PH2) is a rare genetic disorder causing hyperoxaluria and L-glyceric aciduria due to D-glycerate dehydrogenase deficiency. Less is known about PH2 compared to PH1, with uncertainties in its frequency, clinical course, and management.
Area of Science:
- Biochemistry
- Genetics
- Metabolic Disorders
Background:
- Primary hyperoxaluria type 1 (PH1) results from hepatic peroxisomal alanine:glyoxylate aminotransferase deficiency.
- PH1 has hundreds of documented cases since 1925.
- Primary hyperoxaluria type 2 (PH2) is significantly rarer, with only 22 reported patients since 1968.
Observation:
- PH2 is characterized by hyperoxaluria and L-glyceric aciduria.
- The underlying cause of PH2 is a deficiency in D-glycerate dehydrogenase/glyoxylate reductase.
- Limited information exists regarding PH2 compared to PH1.
Findings:
- PH2 is caused by D-glycerate dehydrogenase/glyoxylate reductase deficiency.
- PH2 presents with hyperoxaluria and L-glyceric aciduria.
- The rarity of PH2 contributes to knowledge gaps.
Implications:
- Further research is needed to understand PH2 frequency and clinical spectrum.
- Optimal management strategies for PH2 require further investigation.
- Understanding PH2 biochemical pathways is crucial for potential therapeutic targets.